{
    "2020-05-19": [
        [
            {
                "time": "2020-05-19",
                "original_text": "【主力资金】扫货芯片股，资金疯抢的名单来了",
                "features": {
                    "keywords": [
                        "主力资金",
                        "芯片股",
                        "资金疯抢"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "复星医药参与设立私募股权并投资基金-亚汇网",
                "features": {
                    "keywords": [
                        "复星医药",
                        "私募股权",
                        "投资基金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "福布斯最新上市公司2000强：CVS超辉瑞成新霸主！16家中国药企入围，翰森超越中生",
                "features": {
                    "keywords": [
                        "福布斯",
                        "上市公司2000强",
                        "CVS",
                        "辉瑞",
                        "中国药企",
                        "翰森",
                        "中生"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "最少翻4倍！美股新冠疫苗龙头有哪些？",
                "features": {
                    "keywords": [
                        "美股",
                        "新冠疫苗",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "复星医药(600196.SH)：利妥昔单抗注射液新增两项适应症获药品注册审评受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "利妥昔单抗",
                        "注射液",
                        "适应症",
                        "药品注册审评受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "16家中国药企上榜2020年“全球上市公司2000强”",
                "features": {
                    "keywords": [
                        "中国药企",
                        "全球上市公司2000强"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "多么痛的领悟，你瞧不上的这270只个股股价已经超越五年前！",
                "features": {
                    "keywords": [
                        "个股",
                        "股价",
                        "五年前"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "时代热评 | 陈启宇任上猛增178倍，复星医药近百亿商誉压顶",
                "features": {
                    "keywords": [
                        "复星医药",
                        "陈启宇",
                        "商誉"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "康方生物升3% 中生制药上涨2% 细胞癌新药临床试验佳",
                "features": {
                    "keywords": [
                        "康方生物",
                        "中生制药",
                        "细胞癌",
                        "新药",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "恒生指数高开2.32%报24489点 蓝筹股全线扬创科实业(00669)升4.98%",
                "features": {
                    "keywords": [
                        "恒生指数",
                        "蓝筹股",
                        "创科实业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "智通港股通占比异动统计|5月19日",
                "features": {
                    "keywords": [
                        "智通",
                        "港股通",
                        "占比",
                        "异动"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "智通港股通持股解析|5月19日",
                "features": {
                    "keywords": [
                        "智通",
                        "港股通",
                        "持股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-19",
                "original_text": "【华西医药崔文亮团队】《医药生物行业点评报告：两会医药议题解读：疫苗、创新药、IVD和医疗设备等领域继续成为关注焦点》",
                "features": {
                    "keywords": [
                        "华西医药",
                        "两会",
                        "医药议题",
                        "疫苗",
                        "创新药",
                        "IVD",
                        "医疗设备"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-05-17",
                "original_text": "【山证医药】医药行业周报（20200517）：注射剂一致性评价正式文件出台，行业格局面临巨变",
                "features": {
                    "keywords": [
                        "山证医药",
                        "医药行业",
                        "注射剂",
                        "一致性评价",
                        "行业格局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}